Novartis Safety Efforts Challenged In NJ Zometa Trial

Law360, New York (May 2, 2013, 11:01 PM EDT) -- Counsel for a woman suing Novartis Pharmaceutical Corp. in New Jersey mass tort litigation over its bone drug Zometa grilled current and former employees of the life sciences giant on Thursday in a bid to show that the company fell short in communicating the medication's ties to dead jaw bone.

Witnesses called by plaintiff Beverly Meng on Thursday included Linda Weiss, a former medical information specialist with the company. Meng attorney John J. Beins questioned Weiss about a March 2004 email that urged caution about using...
To view the full article, register now.